Akeso Biopharma Alternatives & Competitors
12 companies similar to Akeso Biopharma — First in class and best in class therapeutic antibodies for patients worldwide....
Companies similar to Akeso Biopharma
Compugen
A clinical-stage cancer immunotherapy company and a pioneer in computational target discov...
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Acepodia
POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
Trellis Bioscience Inc.
Our human mAb TRL1068 disrupts bacterial biofilm and makes traditional antibiotics work ag...
Rival Readout
Competing with Akeso Biopharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Biond Biologics Ltd
Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...
viDA Therapeutics Inc
Developing first-in-class drugs targeting granzymes for the treatment of disease character...
Innovent Biologics
To develop and commercialize high-quality biopharmaceuticals that are affordable to ordina...
Coya Therapeutics, Inc.
Unleashing the power of Tregs to tackle neurodegenerative and autoimmune diseases.
Beihai Biotech
Putting Patients First, Innovation for All
VG Life Sciences
Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through...
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Akeso Biopharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Akeso Biopharma on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.